Certain antibodies inhibit Mycobacterium tuberculosis, the cause of tuberculosis (TB), the infectious disease that claims the most lives worldwide, a study led by UT Southwestern Medical Center ...

Following the event, the content from the plenary session will be made available in the Scientific Publications section of Sutro Biopharma’s website at About Sutro Biopharma Sutro Biopharma, Inc. is ...

Ulcerative colitis is a long-term disease that causes inflammation in the large intestine. It can lead to abdominal pain, diarrhea, bleeding, fatigue, and weight loss. For many people, the disease ...

Traditionally, vaccines protect against one particular pathogen, but in this study, Stanford Medicine researchers created a vaccine that successfully offered immunity from respiratory viruses, ...

Research and Development (R&D) expenses: R&D expenses totaled $44.6 million for the fourth quarter of 2025 and $50.5 million ...

UCSF is teaming up with Nektar to study NKTR-0165, an experimental antibody that activates the TNFR2 receptor, as a treatment ...

Rare but dangerous blood clotting associated with that vaccine as well as AstraZeneca’s had a genetic cause, according to a new paper.

Blood tests revealed that the beverage elicited an immune response, according to preliminary research. But far more safety ...

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, ...

A study led by UT Southwestern Medical Center researchers has found that certain antibodies inhibit Mycobacterium ...

Australian scientists have created a promising new approach for fighting deadly bacteria that no longer respond to antibiotics. The team designed antibodies that latch onto a sugar found only on ...

A wave of fresh science is challenging a century-old treatment and offering hope to the people snakebites harm most—often far from hospitals and help A rinkhals (Hemachatus haemachatus) in Hluhluwe, ...